Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $15.9 million.

  • Mangoceuticals' Non-Current Assets rose 848.04% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year increase of 848.04%. This contributed to the annual value of $15.3 million for FY2024, which is 700100.05% up from last year.
  • As of Q3 2025, Mangoceuticals' Non-Current Assets stood at $15.9 million, which was up 848.04% from $20.7 million recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Non-Current Assets registered a high of $21.6 million during Q1 2025, and its lowest value of $211639.0 during Q1 2024.
  • For the 3-year period, Mangoceuticals' Non-Current Assets averaged around $10.4 million, with its median value being $14.7 million (2024).
  • Examining YoY changes over the last 5 years, Mangoceuticals' Non-Current Assets showed a top increase of 1009528.77% in 2025 and a maximum decrease of 848.04% in 2025.
  • Quarter analysis of 3 years shows Mangoceuticals' Non-Current Assets stood at $215391.0 in 2023, then surged by 7001.0% to $15.3 million in 2024, then rose by 4.18% to $15.9 million in 2025.
  • Its Non-Current Assets was $15.9 million in Q3 2025, compared to $20.7 million in Q2 2025 and $21.6 million in Q1 2025.